SMITH DARREN CHARLTON enters TELIX PHARMACEUTICALS LTD with 10.81K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Ordinary Shares
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 10.81K | Direct |
| Total | 10.81K | 10.81K direct |
Performance Share Appreciation Rights (right to buy)
DirectUnderlying shares
45.45K
Shares owned
N/A
Exercise price
6.15
Expiration
—
Exercise window
—
Share Rights
DirectUnderlying shares
1.11K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Performance Share Appreciation Rights (right to buy)
DirectUnderlying shares
32.46K
Shares owned
N/A
Exercise price
6.15
Expiration
—
Exercise window
—
Share Rights
DirectUnderlying shares
14.74K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Performance Share Appreciation Rights (right to buy)
DirectUnderlying shares
88.50K
Shares owned
N/A
Exercise price
6.90
Expiration
—
Exercise window
—
Underlying
182.26K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Performance Share Appreciation Rights (right to buy) Direct | Ordinary Shares | 6.15 | — | — | 45.45K | N/A |
| Share Rights Direct | Ordinary Shares | 0 | — | — | 1.11K | N/A |
| Performance Share Appreciation Rights (right to buy) Direct | Ordinary Shares | 6.15 | — | — | 32.46K | N/A |
| Share Rights Direct | Ordinary Shares | 0 | — | — | 14.74K | N/A |
| Performance Share Appreciation Rights (right to buy) Direct | Ordinary Shares | 6.90 | — | — | 88.50K | N/A |
| Total | 182.26K | 0.00 | ||||